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Abstract
Background: Information on physical andmentalwellness in renal transplantation is limited. Therefore, we performed across-
sectional study to evaluate anddescribe the different components of physical performanceandqualityof life (QoL) in acohort of
kidney-transplanted patients.
Methods: Physical performance and QoL were determined through the administration of validated tests and questionnaires
[muscle strength, dynamometer handgrip, tactile sensitivity, visual analogue scale (VAS) for pain, Timed Up and Go (TUG) test,
Fatigue Severity Scale (FSS) and the 36-item Short Form Health Survey]. The patients were divided into three groups based on
time elapsed since transplantation: early (in the first 6 months), middle (from 7 to 60 months) and late (>60 months).
Results: Of 132 enrolled patients, 11 patients (8.3%) presented a severe reduction of muscle strength, 63 patients (47%) had
significant bilateral impaired handgrip and tactile sensitivity was altered in 23 patients (17.4%). TUG assessment showed
significant mobility limitation in 29 patients (21.9%). The FSS presented a pathological value in 50 patients (37.3%), while the
mean VAS was 1.8 ± 2.7. There were no significant differences in physical performance parameters among the three patient
groups. There were inverse correlations among different components of physical performance and age, comorbidity and
dialysis vintage, and therewas a direct correlationwith renal function. During the firstmonths after transplantation therewere
limitations in physical, social and emotional activities. Overall, the self-perceived physical performancewas significantly lower
in transplanted patients with respect to the normal reference level.
Conclusion: Kidney-transplanted patientsmay present different degrees of impairment in physical performance and quality of
life. Systematic functional assessment is essential to identify patients needing intensive and personalized rehabilitation
programmes.
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Chronic kidney disease (CKD) causes an early loss of physical and
mental performance associated with a self-perceived poor qual-
ity of life (QoL) [1]. Disability is particularly severe in patients
undergoing haemodialysis (HD) or peritoneal dialysis (PD),
which results in unemployment, depression, pain, low sleep
quality and increased risk for malnutrition, inflammation and
anaemia [2–5]. In patients with defective physical performance,
protein-energy wasting and abnormal body composition are
common and lead to increased hospitalization and mortality
[6]. The strong correlation between physical performance and
clinical, mental and social outcomes has been the thrust to de-
velop tools aimed at quantifying physical performance in pa-
tients on regular dialysis treatment [7–9]. However, even
though the impact of CKD and HD/PD on QoL and physical per-
formance status has been extensively studied, less is known
about these factors in kidney transplanted (KT) patients.
Renal transplant is the best therapeutic expectation for ur-
aemic patients and has been associated with a significant im-
provement in QoL, a reduction in pain and a general increase in
functional capacities [10, 11]. Nevertheless, there is a lack of
quantitative evaluation of the different components of function-
al performance status in KT patients and, as yet, no specific test
has been designed to understand what part physical perform-
ance plays as a determinant of clinical outcomes in transplanted
patients. Such information is necessary both to address selected
patients to rehabilitation programmes and to evaluate cost/ben-
efits of rehabilitation intervention.
This is why we designed this observational study to define
and grade the various aspects of functioning in a population of
KT patients.
Materials and methods
Study design and clinical setting
Wedesigned a cross-sectional observational study in KT patients
on regular follow-up at the Policlinico ‘SanMatteo’ in Pavia (Italy).
From March 2014 to March 2015, all patients with kidney trans-
plants attending the outpatient Nephrology Clinic were invited
to participate in the study. Patients were excluded if they did
not provide informed consent or if they presented with acute in-
fections or cardiovascular events during the last 3 months. On
the date of scheduled outpatient visits, we collected demograph-
ic and clinical data, including age, sex, BMI, cause of end-stage
renal disease, date of transplant, updated haemoglobin (Hb),
serum creatinine, estimated glomerular filtration rate (eGFR)
and current medications.
Laboratory parameters were measured by standard methods.
Creatinine was measured by enzymatic methods and the Modifi-
cation of Diet in Renal Disease (MDRD) equationwas used for GFR
estimation [12]. The Charlson Index (CCI) was used in assess-
ments of comorbidity [13]. Post-induction immunosuppression
included calcineurin inhibitors, mechanistic target of rapamycin
inhibitors (mTORis), mycophenolate mofetil (MMF) and prednis-
one, tailored to patient needs in various combinations.
Patientswere divided into three groups based on time elapsed
since transplantation: early (in the first 6months),middle (from7
to 60 months) and late (>60 months).
The study was conducted in accordance with the Declaration
of Helsinki and was approved by the Ethics Committee of Foun-
dation IRCCS Policlinico ‘San Matteo’ of Pavia, Italy. Written in-
formed consent was obtained from each participant prior to
enrolment in the study.
Functional tests
One of two trained assessors conducted all functional assess-
ments using a standardized protocol. Functional assessments
were performed in a quiet environment under standard condi-
tions and included muscle strength, dynamometer handgrip
strength, tactile sensitivity, visual analogue scale (VAS) for pain,
Timed Up and Go (TUG) test and Fatigue Severity Scale (FSS).
Muscle strength was assessed according to the Medical Re-
search Council (MRC) scale of the upper limbs (biceps brachii
and triceps brachii) and the lower limbs (psoasmajor and iliacus,
quadriceps, hamstrings, tibialis anterior, calves) for a total of 10
muscle groups. An overall MRC score≥40/50was considered indi-
cative of good strength [14].
Handgrip strength, a measure of upper-limbmuscle strength,
was tested using a Jamar handgrip dynamometer, with a single
maximal effort squeeze to the dynamometer grip. Handgrip
strength in the dominant hand >40 kg in males and >20 kg in fe-
males was considered normal [15].
Tactile sensitivity of the upper and lower limbs was assessed
by the Semmes–Weinstein monofilament test. The monofila-
ments were applied to the test site perpendicularly. Patients
were instructed to say ‘yes’ each time they sensed the monofila-
ment on their limbs. If patients failed to sense themonofilament
after it was bent, the test site was considered insensate [16].
A VAS was used for pain evaluation. Values >3 were consid-
ered indicative of pain requiring pharmacological treatments
[17].
The TUG test was used to evaluate functional mobility [18].
The patient was observed and timed in seconds while rising
from an armchair, walking 3m, turning, walking back and sitting
down again. As previously described, longer test times (>10 s)
were considered pathological and predictive of the future need
for placement in a long-term care facility [19].
Finally, muscular fatigue was evaluated by a self-report ques-
tionnaire, the nine-item FSS, as previously reported. Each item
was valuated with a score from 1 to 7 points (range 9–63), and a
score >36 was considered pathological [20].
QoL
QoL was assessed by the Medical Outcomes Study 36-item Short
Form Health Survey (SF-36), a generic instrument translated and
validated in Italian patients with CKD [7]. This instrument is di-
vided into eight dimensions: physical functioning, bodily pain,
role-physical, general health, vitality, social functioning, role-
emotional and mental health. The results of each scale vary
from 0 to 100 (worst to best possible status). The physical and
mental components, respectively, of the eight scales were com-
bined into a physical component summary (PCS) and a mental
component summary (MCS). The two summary measures were
standardized to have amean value of 50 and a standard deviation
(SD) of 10 in the general population [21]. Normal QoL was defined
as a score of >50 points [22].
Statistical analysis
Descriptive analyses were performed for all variables. Continu-
ous variables were reported using mean ± SD or median and
interquartile range (IQR). For categorical variables, absolute num-
bers and percentages were calculated. The 95% confidence inter-
vals (CIs) were computed for the SF-36 PCS andMCS. To compare
patient characteristics according to time since transplant (three
groups), the Fisher exact test, general linear model or analysis
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variables was assessed using Spearman’s rho correlation coeffi-
cient, because of the expected non-normal distribution of the
questionnaires’ scores and to detect non-linear relationships.
Stata 13.1 (StataCorp, College Station, TX, USA) was used for




Of 166 possible participants, 132 [age 52.3 ± 12.4 years, 78 males
(59%)] were enrolled in the study while 27 patients denied con-
sent and 7were excluded because of recent infection. Themajor-
ity of the patients (72.7%) underwent HD before the
transplantation, whereas 27.3% were on PD. Dialysis vintage,
i.e. the time spent in dialysis before transplantation, was 28
(range 18–48) months.
Eighteen patients (13.6%) were diabetic and the main under-
lying nephropathies included glomerulonephritis, nephroangio-
sclerosis and hereditary disease.
The graft was implanted in the right iliac fossa in 119 patients
(89.6%) and in the left iliac fossa in 13 patients (10.4%). The mean
eGFR and Hb were 52.8 ± 22.1 mL/min/1.73 m2 and 12.4 ± 1.6 g/dL,
respectively.
The median time from transplantation was 53.4 months (IQR
18.2–97.3). Twenty-one patients (15.9%) were assessed within 6
months from KT transplantation (early group), 50 (37.9%) be-
tween 7 and 60 months (middle group) and 61 patients (46.2%)
>60 months from transplantation (late group).
These groups did not significantly differ regarding demo-
graphic and clinical characteristics (Table 1).
Physical performance measures
All participants completed the functional assessment. Consider-
ing the totality of the evaluated patients, 103 patients (78%) had
good force in all areas examined, 18 patients (13.6%) had an over-
all muscle strength that was slightly reduced (MRC 40–<45), and
11 (8.3%) had severely reduced muscle strength (MRC < 40).
The specific analysis of the performance of psoas major and
iliacus muscle showed that 99 patients (75%) had good force for
the left psoas and 95 patients (72%) for the right psoas, while
no correlations were found between the side of the transplant
intervention and weakness of the psoas.
Global muscle strength resulted in a significantly inverse cor-
relation with age (r = −0.31 and r = −0.29, P < 0.005, respectively)
and dialysis vintage (r = −0.2, P < 0.05), whereas it was directly
correlated with renal function, expressed as eGFR (r = 0.27,
P < 0.005).
Sixty-three patients (47%) had significant bilateral impaired
handgrip, 29 patients (21.7%) presentedmonolateral impairment,
and 40 subjects (31.3%) showed normal results.
Handgrip strength was directly correlated with eGFR (r = 0.32,
P < 0.001), whereas it was inversely related to dialysis vintage (r =
−0.22, P < 0.05).
Among patients with monolateral impairment, there was a
significantly higher prevalence of subjects with a pretransplant
history of HD when compared with other patients (89% versus
68%; P < 0.05).
Tactile sensitivity to four limbs was preserved in 109 patients
(82.6%), while 14 patients complained of dysesthesia in the lower
limbs (11.2%), 8 in the upper limbs (5.9%) and 1 (0.1%) in all four
limbs. The TUGmobility assessment showedmean values of 9 ±
3.1 s and significant mobility limitations (i.e. TUG >10 s) in 29








N 132 21 50 61
Gender (M/F) 78/54 13/8 31/19 34/27 0.79
Age (years) 52.3 ± 12.4 55.5 ± 10.8 50 ± 11.3 53.1 ± 13.6 0.16
BMI (kg/m2) 24.7 ± 4.8 23 ± 4 25 ± 4.1 25 ± 5.5 0.1
Time on dialysis before KT, months (IQR) 28 (18–48) 30 (24–54) 26 (20–48) 30 (16–48) 0.5
Type of dialysis, n (%)
HD 96 (72.7) 13 (61.9) 37 (74) 45 (75.4) 0.48
PD 36 (27.3) 8 (38.1) 13 (26) 14 (24.6)
Primary cause of ESRD, n (%)
HTN/vascular 36 (27.3) 7 (33.3) 12 (24) 17 (27.9) 0.52
GLN 47 (35.6) 6 (28.7) 24 (48) 17 (27.9)
Hereditary 27 (20.4) 4 (19) 7 (14) 16 (26.2)
Other/UN 22 (16.7) 4 (19) 7 (14) 11 (18)
Time from transplantation, months (IQR) 53.4 (18.2–97.3) 1 (0.9–2) 32 (18.2–43) 102 (81–127) 0.001
Current medications (n/%)
Steroids 70 (53) 18 (85.7) 26 (52) 26 (42.6) 0.002
Calcineurin inhibitors 100 (75.8) 20 (95.2) 37 (74) 43 (70.5) 0.056
MMF 87 (65.9) 18 (85.7) 33 (66) 36 (59) 0.08
mTORi 23 (17.4) 0 9 (18) 14 (22.9) 0.03
Hb levels (g/dL) 12.5 ± 1.6 11.9 ± 1.2 12.7 ± 1.8 12.4 ± 1.6 0.09
eGFR (mL/min) 52.8 ± 22.1 46.2 ± 17.3 56.8 ± 22.3 51.9 ± 22.9 0.1
Active working people, n (%) 83 (63) 12 (60) 31 (62) 40 (65) 0.8
Diabetes, n (%) 18 (13.6) 2 (9.5) 8 (16) 8 (13.1) 0.8
Charlson Index (age-related) 3.7 ± 1.5 4.2 ± 1.5 3.5 ± 1.7 3.6 ± 1.3 0.24
Data are presented as mean ± SD unless otherwise noted. The patients were considered overall and divided according to time elapsed since transplantation.
BMI, bodymass index; KT, kidney transplant; ESRD, end-stage renal disease; HTN, hypertension; GN, primary and secondary glomerulonephritis; UN, unknown aetiology;
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patients (21.9%). Five subjects (3.8%) recalled having fallen at
least once in the past year.
The resulting TUG scores were strictly related to age (r = 0.5, P
< 0.005) and inversely correlated withmuscle strength (r =−0.5, P
< 0.005) and eGFR (r =−0.17, P < 0.05). Ninety-two patients (69.7%)
had a VAS score ≤3, indicative of an insignificant presence of
pain.
The area most affected by pain was the lower limbs (43.8%),
followed by the lumbar spine (31.2%) and upper limbs (8.4%).
The mean FSS was 31 (SD 18) with 50 patients (37.3%) presenting
a clear pathological value. Finally, none of the parameters evalu-
ating physical performance correlated with the type of pretrans-
plant dialytic technique (HD versus PD) and time from
transplantation. Consistently there were no significant differ-
ences among the three patient groups, either when considering
the absolute results of the functional tests (Table 2) or after di-
chotomization according to normality thresholds (Figure 1).
Immunosuppressive treatment
At the time of observation the immunosuppressive treatment in-
cluded steroids in 70 patients (53%), calcineurin inhibitors (cyclo-
sporine or tacrolimus) in 100 patients (75.8%), MMF in 87 patients
(65.9%) and mTORi in 23 (17.4%) patients. The immunosuppres-
sion drugs used changed according to the time from kidney
transplantation. Indeed, a higher percentage of patients evalu-








N 132 21 50 61
MRC 47.3 ± 3.9 46.8 ± 3.5 47.5 ± 4 47.4 ± 4.1 0.74
HG (kg) 25.4 ± 9.3 24.1 ± 9.3 26.0 ± 8.9 25.3 ± 9.8 0.72
Male 29.4 ± 9.2 28.1 ± 9.1 29.2 ± 9.1 30.2 ± 9.6 0.77
Female 19.5 ± 5.7 17.6 ± 5.4 20.8 ± 5.7 19.1 ± 5.8 0.36
Tactile sensitivitya, n (%) 109 (82) 17 (81) 42 (82) 50 (82) 0.91
VAS 1.8 ± 2.7 1.8 ± 2.8 1.4 ± 2.4 2.1 ± 2.9 0.38
TUG test (s) 9 ± 3.1 9.58 ± 3.4 9.13 ± 3.3 8.8 ± 2.8 0.50
FSS 31.4 ± 18 29.7 ± 18.6 34.6 ± 18.3 29.3 ± 17.3 0.28
The patients were considered overall and divided according to time elapsed since transplantation. Data are presented as mean ± SD unless otherwise noted.
aFor tactile sensitivity, the percentage of normal tests is shown.
bGeneral linear regression model.
Fig. 1. Prevalence of normal functional (on x-axis) indices for the entire population (upper left panel) and according to short (upper right), middle (lower left) and long
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ated within 6 months after transplantation took steroids (18/21)
and calcineurin inhibitors (20/21) when compared with patients
with longer transplantation times (steroids 26/61, calcineurin in-
hibitors 43/61; P < 0.05), probably reflecting the switch from calci-
neurin antagonists that occurred during the follow-up (Table 1).
Statistical analysis did not show any relationship between the
immunosuppressive therapies, in particular the use of steroids,
and physical performance parameters both when considering
the totality of patients and the three different groups.
QoL
The majority of scores obtained from the SF-36 questionnaire
were >50, indicating an absence of limitations in the various
items considered (Table 3). The presence of limitations in physic-
al and social functioning, as well as in role-emotional, was sig-
nificantly higher in patients evaluated within the first 6 months
after transplantation when compared with patients with longer
transplant age. When QoL parameters were summarized as
self-perceived mental performance (expressed as MCS) and
self-perceived physical performance (PCS), we found that PCS
was significantly lower in KT patients with respect to the normal
reference level (i.e. >50), independent of time from
transplantation.
Discussion
Although physical performance is a very important determinant
of health and QoL, few studies have explored this topic in KT pa-
tients [23, 24].
The point is relevant because of many factors, some of which
are specific to transplants, such as infections and immunosup-
pressive treatment, and increase the risk for impaired physical
condition, and we canmiss this important determinant of clinic-
al outcomes because we lack adequate attention and tools to de-
tect and grade it. In this study, we assessed several aspects of
physical performance in a well-defined KT population using a
panel of standardized functional tests to build a preliminary de-
scription of the physical state of KT patients based on a con-
trolled, homogeneous method of assessment. A relevant
finding of our study was that, even excluding confounding com-
plications in KT patients, the results of functional tests were very
variable. Nonetheless, we found that kidney transplantation has
a conservative effect on global physical performance; in particu-
lar, it is associated with low rates of pain, physical limitations
and accidental falls. Also, the overall muscle strength and tactile
sensitivity were preserved in ∼80% of patients. However, the
upper limit of arm strength, measured as handgrip, was normal
in only 30% of patients, suggesting a reduction in muscle power
related with a decrease in muscle mass.
Considering the relationship between physical performance
and clinical variables, we found that while time from transplant
did not seem to significantly influence functional parameters,
the main factors associated with the results of functional tests
were age, comorbidity index and time spent in dialysis. This is
not surprising and may account for the differences that we
found between our data and those reported in early studies on
KT patients.
Indeed, the global physical performance of our patients was
significantly better than that previously reported in other obser-
vational studies that demonstrated a high prevalence of func-
tional dependence, a high annual rate of falls and significantly
decreased muscle strength in elderly transplanted patients [25,
26]. These differences may be explained by considering that our
patients were younger than those included in previous studies,
with a significantly lower prevalence of diabetes and cardiovas-
cular diseases, thus resulting in a low dialytic vintage and low co-
morbidity rate.
Moreover, it is interesting to notice that renal function at the
time of evaluation was one of the most significant variables cor-
related with physical performance, probably reflecting the fact
that patients with good graft function present a better metabolic
and ionic profile, which may be associated with better muscle
trophism and performance [27].
In addition, we also found that in patients with monolateral
handgrip impairment, therewas an elevated prevalence of a pre-
transplant history of HD. Therefore, it is possible that in these pa-
tients, monolateral impairment developed as a consequence of
the presence of a vascular access. This finding suggests that the
pretransplant dialysis technique, although not correlated with
global performance status, may equally impact some features
of physical performance.
Analysis of QoL revealed some other interesting issues. In
fact, we found that our patients experienced major limitations
in social and emotional life during the first months after trans-
plantation, probably because of hospitalization and prophylactic
restrictions (use of a face mask, frequent hand washing, avoid-
ance of contact with animals, etc.).
Afterward, there were no differences between transplanted
patients and the normal reference population, with the import-
ant exception of PCS (i.e. the self-perceived physical component
derived from the SF-36), which was substantially lower in KT pa-
tients. These data might seem to contrast with the observation
that MCS (i.e. the self-perceived mental wellness) in our patients
Table 3. Different components of QoL as evaluated by the SF-36 in
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Data are presented as value (95% CI).
aIf 95% CI excludes 50 (reference normal population) it means a significant
difference from the norm.
bEarly group versus middle and late groups.
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was comparable with the normal population. Actually, we think
that these results reflect the way in which KT patients perceive
their illness condition. Indeed, it is possible that the discrepancy
between PCS and MCS might be explained by the fact that the
psychological effect of freedom from dialysis evokes a feeling of
mental well-being that is not suppressed by objective troubles
such as intensive follow-up and the load of immunosuppressive
drugs [28]. Interestingly, this phenomenon was present in all the
patients we evaluated, independent of time from transplant-
ation, indicating that themental component constitutes a funda-
mental (and unexplored) aspect that should be taken into
consideration in the clinical care of these patients.
On designing this study, we were aware of some methodo-
logical limitations, mainly the relatively small number of pa-
tients enrolled and the single-centre cross-sectional design,
which did not permit insights into how physical performance
varies over time and how itmight correlatewith clinical variables
such as changes in steroid dosing and body weight. Moreover, we
did not investigate other important determinants of physical per-
formance status, such as physical activity and lifestyle, which are
other major contributors to physical and mental wellness [29].
In conclusion, our data demonstrate that kidney transplant-
ation presents a general conservative effect on global physical
performance andQoL. Nevertheless, the finding that the distinct-
ive components of physical function may present different de-
grees of impairment underlines that systematic assessment of
physical performance and QoL should be provided for every KT
patient. Therefore, implementation and validation of newmeth-
odologies, such as comprehensive clinical scores obtained by the
use of standardized questionnaires and simple physical tests,
could represent a promising approach and a new field of research
[30]. This information might be of help in guiding clinical deci-
sions, making it possible to programme preventive interventions
andmore extensive evaluation or to monitor the effectiveness of
clinical and behavioural (i.e. lifestyle changes) interventions [31].
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